fda semaglutide approval The #FDA approved the first oral GLP-1 receptor agonist, (#Wegovy pill), for chronic weight management in adults with obesity or overweight with comorbidities, offering a noninjectable alternative with significant weight loss Semaglutide shortage ends as FDA

Michelle Gourdine, Chief Medical Officer at CVS Caremark, explains how combining medication with health coaching and lifestyle support can help patients achieve more sustainable outcomes

Explore the link between Ozempic and sugar excretion in urine

Supports Joint Health & Reduces Inflammation: Turmeric and Grape Seed Extracts in Wellaray help maintain a healthy inflammatory response, which can support joint comfort and mobility, helping you stay active

Citrucel with SmartFiber is proven to help restore and maintain regularity

Heart failure (HF) remains one of the cardiovascular diseases (CVDs) associated with a high unmet medical need due to high morbidity and mortality rates and ...

Neurodegenerative diseases, including Alzheimers Disease (AD) and Parkinsons Disease (PD) are common complications of diabetes, arising from insulin resistance, inflammation, and other pathological processes in the central nervous system